However, EMT-based CTC capture may be required in NSCLC as traditional capture with EpCAM was shown to be effective in only 20% of samples from patients with metastatic NSCLC [19], as opposed to 57% from those with prostate cancer [11]. The gene discussed is EPCAM; the disease is non-small cell lung carcinoma.